LTG’s mechanisms of action and favorable safety profile have led to an investigation into its potential for repurposing in other central nervous system disorders (Table 3), and being chemically unrelated to other anti-epileptic drugs, it has been the subject of emerging research for its potential use in treating other CNS disorders. The gene discussed is TNFSF14; the disease is central nervous system disorder.